Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

ACRO Biomedical Co Ltd

Financial Services US ACBM

0.026USD
0.00(0%)

Last update at 2026-06-22T20:00:00Z

Day Range

0.030.03
LowHigh

52 Week Range

0.00070.04
LowHigh

Fundamentals

  • Previous Close 0.03
  • Market Cap1.56M
  • Volume66
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.19M
  • Revenue Per Share TTM0.004
  • Gross Profit TTM 0.01M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -0.10115M -0.04230M -15.87144M -15.87144M -7.69783M
Minority interest - - - - -
Net income -0.10115M -0.04230M -15.87144M -15.87144M -7.70208M
Selling general administrative - 0.04M - 5.93M 2.67M
Selling and marketing expenses - - - - -
Gross profit - - 0.14M 0.14M 0.26M
Reconciled depreciation - - - - -
Ebit - - -15.86974M -15.86974M -7.69358M
Ebitda -0.15402M - -15.86974M - -7.69358M
Depreciation and amortization 8.79M - 15.87M - 7.69M
Non operating income net other - - - - -
Operating income -0.15402M -0.03796M -15.86974M -15.86974M -7.69358M
Other operating expenses 0.15M - 16.53M - 8.89M
Interest expense 0.00915M 0.00434M 0.00171M 0.00171M 0.00425M
Tax provision - 0.00000M - 0.00000M 0.00000M
Interest income - - - - -
Net interest income - -0.00434M - -0.00171M -0.00425M
Extraordinary items - - - - -
Non recurring - - - - 5.29M
Other items - - - - -
Income tax expense - - -15.86974M - 0.00425M
Total revenue - 0.00000M 0.66M 0.66M 1.20M
Total operating expenses 0.15M 0.04M 16.01M 16.53M 7.95M
Cost of revenue - - 0.52M 0.52M 0.94M
Total other income expense net 0.05M - -0.00171M - -0.00425M
Discontinued operations - - - - -
Net income from continuing ops - -0.04230M - -15.87144M -7.69358M
Net income applicable to common shares - - - -15.87144M -7.69783M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 0.01M 0.03M 0.69M 0.69M 0.76M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.01000M - 0.00119M - 0.00117M
Total liab 0.40M 0.33M 0.20M 0.20M 0.12M
Total stockholder equity -0.38696M -0.29497M 0.49M 0.49M 0.64M
Deferred long term liab - - - - -
Other current liab 0.10M - 0.08M 0.02M 0.02M
Common stock 0.06M - 0.06M 0.06M 0.06M
Capital stock - 0.06M - 0.06M 0.06M
Retained earnings -32.75894M -32.65780M -23.80793M -23.80793M -7.93648M
Other liab - - - - -
Good will - - - - -
Other assets - - - 0.00423M 0.00423M
Cash 0.00410M 0.00048M 0.00585M 0.00585M 0.10M
Cash and equivalents - - - - -
Total current liabilities 0.40M 0.33M 0.20M 0.20M 0.09M
Current deferred revenue 0.02M - 0.02M - 0.02M
Net debt 0.32M - 0.02M - -0.04482M
Short term debt 0.33M - 0.03M - 0.02M
Short long term debt - - - - -
Short long term debt total 0.33M - 0.03M - 0.05M
Other stockholder equity 32.31M - 16.17M -8.06098M 8.52M
Property plant equipment - - - 0.03M 0.05M
Total current assets 0.01M 0.00508M 0.66M 0.66M 0.71M
Long term investments - - - - -
Net tangible assets - - - 0.49M 0.64M
Short term investments - - - - -
Net receivables - - 0.64M 0.64M 0.60M
Long term debt - - - - -
Inventory - - 0.01M 0.01M 0.01M
Accounts payable 0.06M 0.15M 0.08M 0.08M 0.03M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - -8.06098M - -
Additional paid in capital - - - - -
Common stock total equity - - - - 0.06M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -7.93648M
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.00460M - 0.00423M - 0.00423M
Deferred long term asset charges - - - - -
Non current assets total 0.03M 0.03M 0.03M 0.03M 0.05M
Capital lease obligations - 0.03M - 0.03M 0.05M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - - - - -
Change to liabilities - - - 0.05M 0.00146M
Total cashflows from investing activities - - - - -
Net borrowings - - - 0.06M 0.02M
Total cash from financing activities 0.20M 0.04M 0.06M 0.06M -0.22221M
Change to operating activities - - - -0.00002M -0.00017M
Net income -0.10115M -0.04230M -15.87144M -15.87144M -7.69783M
Change in cash 0.00362M 0.00010M -0.08940M -0.08940M 0.08M
Begin period cash flow 0.00048M 0.00038M 0.10M 0.10M 0.02M
End period cash flow 0.00410M 0.00048M 0.00585M 0.00585M 0.10M
Total cash from operating activities -0.19630M -0.03669M -0.14748M -0.14748M 0.30M
Issuance of capital stock - - - - -
Depreciation - - - - -
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - 0.00000M 0.94M
Change to account receivables 0.16M 0.00000M -0.04050M -0.04050M -0.59800M
Sale purchase of stock - - - - -
Other cashflows from financing activities 0.20M - 0.06M - -0.22221M
Change to netincome - - - 15.71M 7.65M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - - -0.59800M
Cash flows other operating - - - - -0.00428M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - 0.08M
Change in working capital -0.04228M 0.00127M 0.00986M 0.00986M 0.34M
Stock based compensation 8.06M 0.00000M 15.71M 15.71M 7.65M
Other non cash items -0.05288M 0.00434M 0.00171M 0.00171M 0.00445M
Free cash flow -0.19630M -0.03669M -0.14748M -0.14748M 0.30M

Peer Comparison

Sector: Financial Services Industry: Shell Companies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ACBM
ACRO Biomedical Co Ltd		 - -% 0.03 - - 8.07 518.48 193.57 -10.9914
CLUS
CLUS		 - -% 200.00 - - 0.09 0.92 0.72 -8.9658
SVMB
SavMobi Technology Inc.		 - -% 1.00 - - 239.23 - 363.28 -319.6012
PBAJ
Petro Usa Inc		 - -% 0.0005 - - - - -9042.9978
ALSAF
ALSAF		 - -% 15.40 - - - 0.85

Reports Covered

Stock Research & News

View All

Profile

Acro Biomedical Co., Ltd. engages in the development and marketing of nutritional products in Indiana and internationally. It is involved in the development and sale of cordyceps related products, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. was incorporated in 2014 and is based in Fishers, Indiana.

ACRO Biomedical Co Ltd

12175 Visionary Way, Fishers, IN, United States, 46038

Key Executives

Name Title Year Born
Mr. An-Tao Fong Managing Director NA
Mr. Pao-Chi Chu Chairman, CEO, CFO, Pres & Sec. 1954
Mr. Che-Li Lin VP of Technical NA
Mr. Cheng-Hsiang Kao Managing Director NA
Mr. Yun-Yuan Chu Managing Director NA
Mr. Pao-Chi Chu CEO, CFO, President, Secretary & Director 1954
Mr. Jer-Li Lin Vice President of Technical NA
Ms. Yu-Ting Su Chairman, CEO, CFO, President & Secretary 1988

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions